Compounds > 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin
Page last updated: 2024-09-05

3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and aclarubicin

3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin has been researched along with aclarubicin in 1 studies

Compound Research Comparison

Studies
(3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin)		Trials
(3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin)		Recent Studies (post-2010)
(3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin)		Studies
(aclarubicin)		Trials
(aclarubicin)		Recent Studies (post-2010) (aclarubicin)
380082697105

Protein Interaction Comparison

ProteinTaxonomy3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin (IC50)aclarubicin (IC50)
72 kDa type IV collagenaseHomo sapiens (human)9.9
5-hydroxytryptamine receptor 2BHomo sapiens (human)1.106

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coley, HM; Twentyman, PR; Workman, P1

Other Studies

1 other study(ies) available for 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and aclarubicin

ArticleYear
9-Alkyl, morpholinyl anthracyclines in the circumvention of multidrug resistance.
    European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:6

    Topics: Aclarubicin; Adjuvants, Immunologic; Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Doxorubicin; Drug Resistance; Humans; Lung Neoplasms; Mammary Neoplasms, Experimental; Membrane Glycoproteins; Mice; Neoplasm Proteins; Tumor Cells, Cultured

1990